Activated Microglia Disrupt the Blood-Brain Barrier and Induce Chemokines and Cytokines in a Rat Model

Overview

Journal Front Cell Neurosci

Specialty Cell Biology

Date 2019 Jan 9

PMID 30618641

Citations 59

Authors

Yukari Shigemoto-Mogami

Kazue Hoshikawa

Kaoru Sato

Affiliations

Soon will be listed here.

Abstract

Severe neuroinflammation is associated with blood brain barrier (BBB) disruption in CNS diseases. Although microglial activation and the subsequent changes in cytokine/chemokine (C/C) concentrations are thought to be key steps in the development of neuroinflammation, little data are available concerning the interaction of microglia with BBB cells. In this study, we investigated this interaction by adding LPS-activated microglia (LPS-MG) to the abluminal side of a BBB model composed of endothelial cells (EC), pericytes (Peri) and astrocytes (Ast). We then examined the abluminal concentrations of 27 C/Cs and the interactions between the LPS-MG and BBB cells. LPS-MG caused collapse of the BBB, revealed by decreases in the trans-endothelial electrical resistance (TEER) and by changes in the expression levels of tight junction (TJ) proteins. Under these conditions, 19 C/Cs were markedly increased on the abluminal side. Unexpectedly, although LPS-MG alone released 10 of the 19 C/Cs, their concentrations were much lower than those detected on the abluminal side of the BBB model supplemented with LPS-MG. Co-culture of LPS-MG with Ast caused marked increases in 12 of the 19 C/Cs, while co-culture of LPS-MG with EC and Peri resulted in a significant increase in only 1 of the 19 C/Cs (fractalkine). These results suggest that C/C dynamics in this system are not only caused by activated microglia but also are due to the interaction between activated microglia and astrocytes.

Citing Articles

The Involvement of Glial Cells in Blood-Brain Barrier Damage in Neuroimmune Diseases.

Nagata S, Yamasaki R Int J Mol Sci. 2024; 25(22).

PMID: 39596390 PMC: 11594741. DOI: 10.3390/ijms252212323.

The association between precuneus cortex thickness and mild behavioral impairment in patients with mild stroke.

Liu Z, Xu Z, Yan A, Zhang P, Wei W Brain Imaging Behav. 2024; 19(1):99-110.

PMID: 39531165 DOI: 10.1007/s11682-024-00955-x.

Neuroinflammatory responses and blood-brain barrier injury in chronic alcohol exposure: role of purinergic P2 × 7 Receptor signaling.

Togre N, Mekala N, Bhoj P, Mogadala N, Winfield M, Trivedi J J Neuroinflammation. 2024; 21(1):244.

PMID: 39342243 PMC: 11439317. DOI: 10.1186/s12974-024-03230-4.

The arrangements of the microvasculature and surrounding glial cells are linked to blood-brain barrier formation in the cerebral cortex.

Shigemoto-Mogami Y, Nakayama-Kitamura K, Sato K Front Neuroanat. 2024; 18:1438190.

PMID: 39170850 PMC: 11335649. DOI: 10.3389/fnana.2024.1438190.

Exosomes: the next-generation therapeutic platform for ischemic stroke.

Yin W, Ma H, Qu Y, Ren J, Sun Y, Guo Z Neural Regen Res. 2024; 20(5):1221-1235.

PMID: 39075892 PMC: 11624871. DOI: 10.4103/NRR.NRR-D-23-02051.

References

Paul R, Koedel U, Winkler F, Kieseier B, Fontana A, Kopf M . Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis. Brain. 2003; 126(Pt 8):1873-82. DOI: 10.1093/brain/awg171. View

Nakajima K, Tsuzaki N, Shimojo M, Hamanoue M, Kohsaka S . Microglia isolated from rat brain secrete a urokinase-type plasminogen activator. Brain Res. 1992; 577(2):285-92. DOI: 10.1016/0006-8993(92)90285-h. View

Nimmerjahn A, Kirchhoff F, Helmchen F . Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005; 308(5726):1314-8. DOI: 10.1126/science.1110647. View

Yenari M, Xu L, Tang X, Qiao Y, Giffard R . Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke. 2006; 37(4):1087-93. DOI: 10.1161/01.STR.0000206281.77178.ac. View

Ubogu E, Callahan M, Tucky B, Ransohoff R . Determinants of CCL5-driven mononuclear cell migration across the blood-brain barrier. Implications for therapeutically modulating neuroinflammation. J Neuroimmunol. 2006; 179(1-2):132-44. DOI: 10.1016/j.jneuroim.2006.06.004. View

Argaw A, Zhang Y, Snyder B, Zhao M, Kopp N, Lee S . IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol. 2006; 177(8):5574-84. DOI: 10.4049/jimmunol.177.8.5574. View

Oby E, Janigro D . The blood-brain barrier and epilepsy. Epilepsia. 2006; 47(11):1761-74. DOI: 10.1111/j.1528-1167.2006.00817.x. View

Desai B, Monahan A, Carvey P, Hendey B . Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy. Cell Transplant. 2007; 16(3):285-99. DOI: 10.3727/000000007783464731. View

Afonso P, Ozden S, Prevost M, Schmitt C, Seilhean D, Weksler B . Human blood-brain barrier disruption by retroviral-infected lymphocytes: role of myosin light chain kinase in endothelial tight-junction disorganization. J Immunol. 2007; 179(4):2576-83. DOI: 10.4049/jimmunol.179.4.2576. View

10.

Shaftel S, Carlson T, Olschowka J, Kyrkanides S, Matousek S, OBanion M . Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration. J Neurosci. 2007; 27(35):9301-9. PMC: 6673122. DOI: 10.1523/JNEUROSCI.1418-07.2007. View

11.

McCaffrey G, Seelbach M, Staatz W, Nametz N, Quigley C, Campos C . Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia. J Neurochem. 2008; 106(6):2395-409. PMC: 2656385. DOI: 10.1111/j.1471-4159.2008.05582.x. View

12.

Nakagawa S, Deli M, Kawaguchi H, Shimizudani T, Shimono T, Kittel A . A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem Int. 2008; 54(3-4):253-63. DOI: 10.1016/j.neuint.2008.12.002. View

13.

Nakagawa S, Niwa M . [Blood-Brain Barrier (BBB)]. Nihon Yakurigaku Zasshi. 2009; 133(3):170-2. View

14.

Abbott N, Patabendige A, Dolman D, Yusof S, Begley D . Structure and function of the blood-brain barrier. Neurobiol Dis. 2009; 37(1):13-25. DOI: 10.1016/j.nbd.2009.07.030. View

15.

Graeber M, Streit W . Microglia: biology and pathology. Acta Neuropathol. 2009; 119(1):89-105. DOI: 10.1007/s00401-009-0622-0. View

16.

Nishioku T, Matsumoto J, Dohgu S, Sumi N, Miyao K, Takata F . Tumor necrosis factor-alpha mediates the blood-brain barrier dysfunction induced by activated microglia in mouse brain microvascular endothelial cells. J Pharmacol Sci. 2010; 112(2):251-4. DOI: 10.1254/jphs.09292sc. View

17.

Zlokovic B . Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci. 2011; 12(12):723-38. PMC: 4036520. DOI: 10.1038/nrn3114. View

18.

Yao Y, Tsirka S . Monocyte chemoattractant protein-1 and the blood-brain barrier. Cell Mol Life Sci. 2013; 71(4):683-97. PMC: 3946874. DOI: 10.1007/s00018-013-1459-1. View

19.

Shigemoto-Mogami Y, Hoshikawa K, Goldman J, Sekino Y, Sato K . Microglia enhance neurogenesis and oligodendrogenesis in the early postnatal subventricular zone. J Neurosci. 2014; 34(6):2231-43. PMC: 3913870. DOI: 10.1523/JNEUROSCI.1619-13.2014. View

20.

Bataveljic D, Milosevic M, Radenovic L, Andjus P . Novel molecular biomarkers at the blood-brain barrier in ALS. Biomed Res Int. 2014; 2014:907545. PMC: 4037612. DOI: 10.1155/2014/907545. View